GCTK GlucoTrack, Inc. logo

GCTK GlucoTrack, Inc.

Healthcare
$0.50+8.23%ClosedMarket Cap: $283,728

As of 2026-05-25

Valuation

View Details

P/E (TTM)

PEG

P/B

-0.96

P/S

0.00

EV/EBITDA

0.22

DCF Value

$6.81

FCF Yield

-5792.9%

Div Yield

0.0%

Margins & Returns

Gross Margin

0.0%

Operating Margin

0.0%

Net Margin

0.0%

ROE

-582.0%

ROA

-387.7%

ROIC

1378.9%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$0.00$-4.3M$
Q4 null$0.00$-3.6M$
FY null$0.00$-19.4M$
Q3 null$0.00$-4.2M$

Trading Activity

Insider Trades

View All
Malave Luisdirector
SellTue Oct 07
Malave Luisdirector
SellTue Oct 07
Malave Luisdirector
SellTue Oct 07
Malave Luisdirector
SellTue Oct 07
Carter Erin Catherinedirector
SellTue Oct 07

Company Info

Sector

Healthcare

Industry

Medical - Instruments & Supplies

Country

IL

Exchange

Beta

0.72

GlucoTrack, Inc., a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for use by people suffering from diabetes and pre-diabetics in Israel and internationally. It develops GlucoTrack glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel.

Peers